The amyloid-β oligomer hypothesis: beginning of the third decade
The amyloid-β oligomer (AβO) hypothesis was introduced in 1998. It proposed that the brain
damage leading to Alzheimer's disease (AD) was instigated by soluble, ligand-like AβOs …
damage leading to Alzheimer's disease (AD) was instigated by soluble, ligand-like AβOs …
BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative brain disorder
with no current cure. One of the important therapeutic approaches of AD is the inhibition of β …
with no current cure. One of the important therapeutic approaches of AD is the inhibition of β …
Clusterin in Alzheimer's disease: mechanisms, genetics, and lessons from other pathologies
EM Foster, A Dangla-Valls, S Lovestone… - Frontiers in …, 2019 - frontiersin.org
Clusterin (CLU) or APOJ is a multifunctional glycoprotein that has been implicated in several
physiological and pathological states, including Alzheimer's disease (AD). With a prominent …
physiological and pathological states, including Alzheimer's disease (AD). With a prominent …
Alzheimer's disease risk genes and mechanisms of disease pathogenesis
We review the genetic risk factors for late-onset Alzheimer's disease (AD) and their role in
AD pathogenesis. More recent advances in understanding of the human genome …
AD pathogenesis. More recent advances in understanding of the human genome …
Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes
Deficiency in cerebral amyloid β-protein (Aβ) clearance is implicated in the pathogenesis of
the common late-onset forms of Alzheimer's disease (AD). Accumulation of misfolded Aβ in …
the common late-onset forms of Alzheimer's disease (AD). Accumulation of misfolded Aβ in …
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
We undertook a two-stage genome-wide association study (GWAS) of Alzheimer's disease
(AD) involving over 16,000 individuals, the most powerful AD GWAS to date. In stage 1 …
(AD) involving over 16,000 individuals, the most powerful AD GWAS to date. In stage 1 …
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
The gene encoding apolipoprotein E (APOE) on chromosome 19 is the only confirmed
susceptibility locus for late-onset Alzheimer's disease. To identify other risk loci, we …
susceptibility locus for late-onset Alzheimer's disease. To identify other risk loci, we …
Amyloid β-Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression
DA Butterfield, AM Swomley… - Antioxidants & redox …, 2013 - liebertpub.com
Significance: Alzheimer disease (AD) is an age-related neurodegenerative disease. AD is
characterized by progressive cognitive impairment. One of the main histopathological …
characterized by progressive cognitive impairment. One of the main histopathological …
Molecular mechanisms and genetics of oxidative stress in Alzheimer's disease
F Cioffi, RHI Adam, K Broersen - Journal of Alzheimer's …, 2019 - content.iospress.com
Alzheimer's disease is the most common neurodegenerative disorder that can cause
dementia in elderly over 60 years of age. One of the disease hallmarks is oxidative stress …
dementia in elderly over 60 years of age. One of the disease hallmarks is oxidative stress …
Diffusible, nonfibrillar ligands derived from Aβ1–42 are potent central nervous system neurotoxins
MP Lambert, AK Barlow, BA Chromy… - Proceedings of the …, 1998 - National Acad Sciences
Aβ1–42 is a self-associating peptide whose neurotoxic derivatives are thought to play a role
in Alzheimer's pathogenesis. Neurotoxicity of amyloid β protein (Aβ) has been attributed to …
in Alzheimer's pathogenesis. Neurotoxicity of amyloid β protein (Aβ) has been attributed to …